What is the Fiscal Year for LivaNova?
Date: November 13, 2026
LivaNova's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Gloucester
Industry
Medical Equipment Manufacturing
Stock Symbol
LIVN
Website
https://livanova.comDescription
LivaNova PLC is a global medical technology company built on 50+ years of experience and a Vision to change the trajectory of lives for a new day. Our Mission is to create ingenious medical solutions that ignite patient turnarounds. At LivaNova, we understand the importance of bringing both clinical and economic value to our customers. We are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. LivaNova is listed on the Nasdaq stock exchange under the ticker symbol “LIVN.” LivaNova has approximately 3,000 employees worldwide. Our registered office is in the United Kingdom and we maintain a presence in more than 100 countries. As a worldwide leader in cardiopulmonary and neuromodulation, we don’t just treat conditions—we aspire to alter the course of lives. So from patients seeking answers to impossible situations to clinicians striving to do their best work to employees finding a place where they can change the world— Welcome to LivaNova. Welcome to your new life.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like LivaNova and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.
